MOUSCRON PHARMA
Board
3 directors, 1 in day-to-day management, last change in May 2026ALEXO BV
Chair of the board and director, permanent representative Olivier Delaere
chair of the board appointed by deed of 06-12-2022
director since 01-09-2022
also on the board of 45 other companies
listed in the 2025 annual accounts, filed on 12-05-2026
SODIAP BV
Director and managing director, permanent representative Tom Goderis
director since 22-12-2020
managing director in office according to the deed of 04-08-2026
term without a fixed end
also on the board of 23 other companies
listed in the 2025 annual accounts, filed on 12-05-2026
Permanent representatives 3
Mandates through the years
6 names, the dashed line is todaySODIAP
Director, Managing director
Director, Managing director
ALEXO
Chair of the board
Chair of the board
SRL KST Pharma
Director
Director
ARISTO
Director
Director
COENE Frank Philip Cornelius
Director
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- SODIAP
- Director, from 22-12-2020 to date
- Managing director, since before 04-08-2026
- ALEXO
- Director, from 01-09-2022 to 19-05-2026
- Chair of the board, from 01-09-2022 to date
- SRL KST Pharma
- Director, appointed by deed of 04-08-2026, still in office
- ARISTO
- Director, from 22-12-2020 to 31-08-2022
- COENE Frank Philip Cornelius
- Director, until 07-01-2021
- SOCIAAL DIENSTBETOON AAN APOTHEKERS
- Director, from before 07-01-2021, no longer listed in the 2025 annual accounts
Control
Parent
Equity €33.0m
Profit €411,580 in 2025 (profit €136,567 in 2024)
Checked score 86
Source: accounts SODIAP 2025
100%
This company
MOUSCRON PHARMA
Equity €2.0m
Profit €70,063 in 2025
Further up the chainFEBELCO 100%PHARMACIE BIA 100%
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
Source: lists of holdings in the owners' accounts
Articles of association
deed of 07-01-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of April at 09:30